Hyperbaric Oxygen Therapy Indications

The Undersea and Hyperbaric Medical Society (UHMS) is an international, non-profit organization serving over 2,400 members from more than 50 countries. The UHMS is the primary source of scientific information for diving and hyperbaric medicine physiology worldwide, the breadth of which is illustrated in the triennial report, Hyperbaric Oxygen Therapy Indications. With leading experts authoring chapters in their respective fields, this publication continues to provide the most current and up to date guidance and support for scientists and practitioners of hyperbaric oxygen therapy.

Hyperbaric Oxygen Therapy Indications, currently in its thirteenth edition, has grown in size and depth to reflect the evolution of the literature on the approved use of hyperbarics from both a clinical practice standpoint and insurance coverage perspective. To date, the committee recognizes fourteen indications, including the new indication, idiopathic sudden sensorineural hearing loss.

Additionally, this book continues to be used by the Centers for Medicare and Medicaid Services and other third party insurance carriers in determining payment for HBO2 services.

Updates in the Thirteenth Edition

• Inclusion of the newest HBOT indication approved by the UHMS: idiopathic sudden sensorineural hearing loss
• Five additional chapters, one new appendix, and two new indexes:
  • Additional chapters are: mechanisms of action of hyperbaric oxygen therapy; pre-treatment and pre-conditioning; randomized control trials of diving & hyperbaric medicine; regulatory considerations for TBI; and a product summary: hyperbaric medicine for post-concussive syndrome
  • New appendix on the approved indications for HBOT
  • A new reference index and a new index of terms
• This thirteenth edition was professionally published